| Current Price | $47.30 | Mkt Cap | $2.5B |
|---|---|---|---|
| Open | $50.20 | P/E Ratio | -17.03 |
| Prev. Close | $47.30 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $46.22 - $50.20 | Volume | 620,978 |
| 52-Wk Range | $28.99 - $79.65 | Avg. Daily Vol. | 379,422 |
| Current Price | $47.30 | Mkt Cap | $2.5B |
|---|---|---|---|
| Open | $50.20 | P/E Ratio | -17.03 |
| Prev. Close | $47.30 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $46.22 - $50.20 | Volume | 620,978 |
| 52-Wk Range | $28.99 - $79.65 | Avg. Daily Vol. | 379,422 |
The best Bull and Bear pitches based on recency and number of recommendations.
Prothena doesn't seem to have impressed the street much with their recent announcement of positive interim data from the phase I/II trial of NEOD001 anti-amyloid mAb for amyloid light chain (AL) amyloidosis. The company reported a 50% cardiac… More
Prothena has a healthy market cap of 450M despite a very immature pipeline and a questionable therapeutic platform. The company purports to treat amyloidosis and Parkinson's disease with monoclonal antibodies against abnormally folded proteins, but… More
Read the most recent pitches from players about PRTA.
Find the members with the highest scoring picks in PRTA.
CMFBLSH (71.17) Score: +529.32
The Score Leader is the player with the highest score across all their picks in PRTA.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| CMFBLSH | 71.17 | 8/27/2019 |
|
5Y | $6.97 | +578.62% | +49.30% | +529.32 | 0 Comment | |
| DeathStock | < 20 | 5/13/2019 |
|
5Y | $9.93 | +376.33% | +53.66% | +322.67 | 0 Comment | |
| northcutt0 | < 20 | 4/23/2018 |
|
5Y | $11.51 | +310.86% | +61.90% | +248.96 | 0 Comment | |
| ClientNein | < 20 | 4/24/2018 |
|
5Y | $11.55 | +309.52% | +61.44% | +248.08 | 0 Comment | |
| drugtrader | 34.40 | 9/18/2018 |
|
5Y | $12.60 | +275.40% | +49.26% | +226.14 | 0 Comment | |
| rowtheboat | 39.13 | 2/5/2021 |
|
3Y | $14.70 | +221.77% | +11.34% | +210.43 | 0 Comment | |
| portefeuille3 | 92.54 | 5/21/2018 |
|
5Y | $14.26 | +231.70% | +58.32% | +173.38 | 0 Comment | |
| portefeuille | 98.33 | 5/18/2018 |
|
5Y | $15.30 | +209.15% | +59.24% | +149.91 | 0 Comment | |
| Halffrenzy | 64.81 | 2/28/2014 |
|
5Y | $36.79 | +28.57% | +131.26% | +102.70 | 0 Comment | |
| maven12 | < 20 | 6/19/2013 |
|
5Y | $13.10 | +261.01% | +161.39% | +99.63 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
